These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7678941)

  • 1. [Primary Hodgkin disease of the lung].
    Anchisi S; Pugin P; Baur A
    Schweiz Med Wochenschr; 1993 Jan; 123(3):65-6. PubMed ID: 7678941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathoracic Hodgkin's disease. A case presentation with multiple pulmonary nodules in the absence of mediastinal or hilar node disease.
    Strum SB; Weiss A; McDermed JE; Rosen VJ
    Cancer; 1985 Oct; 56(8):1953-6. PubMed ID: 2411383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary pulmonary Hodgkin's disease].
    Hosoi K; Chikuie N; Min KY; Satoh T; Tokumine Y; Ishikawa K; Maeda H; Ueda K; Inoue M
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1399-401. PubMed ID: 16097597
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controversial aspects in the current treatment of Hodgkin's disease].
    Vicente J
    Rev Clin Esp; 1987 Feb; 180(3):158-64. PubMed ID: 2437622
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Hodgkin's disease with ABVD].
    Montserrat E; Carreras E; Rozman C; Olivé T; Bladé J; Cervantes F; Feliu E; Gardella S; Grañena A; Marín P
    Med Clin (Barc); 1984 Dec; 83(18):739-41. PubMed ID: 6084157
    [No Abstract]   [Full Text] [Related]  

  • 6. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
    Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
    Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiogenic shock during polychemotherapy in a patient with Hodgkin's disease].
    Drzewoski J; Chojnowski K; Olszańska-Skorek T; Krykowski E
    Kardiol Pol; 1986; 29(8):555-9. PubMed ID: 2435945
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controversy regarding the treatment of Hodgkin's disease].
    Balwierz W; Armata J
    Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966
    [No Abstract]   [Full Text] [Related]  

  • 9. [Function of the lungs in patients with Hodgkin's disease after chemotherapy and radiotherapy].
    Milanowski A; Kulus M; Matysiak M; Ochocka M
    Pediatr Pol; 1988 Nov; 63(11):747-52. PubMed ID: 2473435
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of pulmonary histiocytosis X after chemotherapy for Hodgkin disease.
    Shanley DJ; Lerud KS; Luetkehans TJ
    AJR Am J Roentgenol; 1990 Oct; 155(4):741-2. PubMed ID: 1698017
    [No Abstract]   [Full Text] [Related]  

  • 11. [A rare case of metastasis of Hodgkin's disease to the spinal cord].
    Pierzchała K; Luciak M; Kwieciński J
    Neurol Neurochir Pol; 1992; 26(4):555-9. PubMed ID: 1283006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 14. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rescue treatment in Hodgkin's disease].
    Zori Comba A; Koziner B
    Sangre (Barc); 1987; 32(1):67-76. PubMed ID: 2438788
    [No Abstract]   [Full Text] [Related]  

  • 16. Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data?
    Basaran G; Agaoglu F; Basaran M
    J Clin Oncol; 2010 Sep; 28(27):e485-6; author reply e487. PubMed ID: 20606082
    [No Abstract]   [Full Text] [Related]  

  • 17. The cure of Hodgkin's disease with drugs.
    DeVita VT; Hubbard SM; Moxley JH
    Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol].
    Gabryś K; Kotlarek-Haus S; Sciborski R
    Pol Tyg Lek; 1986 Feb; 41(7):195-8. PubMed ID: 2423994
    [No Abstract]   [Full Text] [Related]  

  • 19. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R; Nomdedeu J; Brunet S
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
    Ekert H
    Cancer Treat Res; 1989; 41():241-6. PubMed ID: 2484293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.